Idiosyncratic drug-induced thrombocytopenia;Les thrombopénies médicamenteuses idiosyncrasiques

Revue de Medecine Interne

Volumn 30, Issue 10, 2009, Pages 866-871

  Serraj, K ^a,b   Mecili, M ^a   Aouni, M ^b   Maaouni, A ^b   Andres E ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b hôpitaux universitaires de Rabat   (Morocco)

Author keywords

Cytopenia; Drugs; Idiosyncratic; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; ANTIVIRUS AGENT; BENZENE DERIVATIVE; CHLORPROMAZINE; COLCHICINE; COTRIMOXAZOLE; DICLOFENAC; DIGITALIS; FOLIC ACID ANTAGONIST; GOLD SALT; HALOPERIDOL; HEPARIN; LINEZOLID; MECLOFENAMIC ACID; METHYLDOPA; PARACETAMOL; QUINIDINE; QUININE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIFAMPICIN; ROMIPLOSTIM; SULFONAMIDE; THIAZIDE DIURETIC AGENT; TICLOPIDINE; TIROFIBAN; UNINDEXED DRUG; VALPROIC ACID; VANCOMYCIN; VERAPAMIL;

ANAMNESIS; BLEEDING; BLOOD ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; SHORT SURVEY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY; HUMANS; THROMBOCYTOPENIA;

EID: 70349617684     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.02.024     Document Type: Short Survey

References (44)

1. Aster R.H., and Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 357 (2007) 580-587
2. Visentin G.P., and Liu C.Y. Drug-induced thrombocytopenia. Hematol Oncol Clin North Am 21 (2007) 685-696
3. George J.N., Raskob G.E., Shah S.R., Rizvi M., Hamilton S.A., Osborne S., et al. Drug-induced thrombocytopenia. A systematic review of published case reports. Ann Intern Med 129 (1998) 886-890
4. Li X., Swisher K.K., Vesely S.K., and George J.N. Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf 30 (2007) 185-186
5. van den Bemt P.M., Meyboom R.H., and Egberts A.C. Drug-induced immune thrombocytopenia. Drug Saf 27 (2004) 1243-1252
6. Godeau B, Bierling P. Thrombopénies. In : Encyclopédie pratique de medicine. Encycl Med Chir (Elsevier, Paris), AKOS 4-0080, 1998, p. 5.
7. Murphy W.G., and Kelton J.G. Idiosyncratic drug-induced thrombocytopenia. Curr Stud Hematol Blood Transfus 54 (1988) 71-88
8. Theophile H., Begaud B., Martin K., Laporte J.R., and Capella D. Incidence of agranulocytosis in Southwest France. Eur J Epidemiol 19 (2004) 563-565
9. Strom B.L., Carson J.L., Schinnar R., Snyder E.S., and Shaw M. Descriptive epidemiology of agranulocytosis. Arch Intern Med 152 (1992) 1475-1480
10. Kaufman D.W., Kelly J.P., Johannes C.B., Sandler A., Harmon D., Stolley P.D., et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 82 (1993) 2714-2718
11. Aster R.H. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 36 (1999) 2-6
12. Carey P.J. Drug-induced myelosuppression: diagnosis and management. Drug Saf 26 (2003) 691-706
13. Rutherford C.J., and Frenkel E.P. Thrombocytopenia. Issues in diagnosis and therapy. Med Clin North Am 78 (1994) 555-575
14. Saif M.W., and McGee P.J. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature. JOP 6 (2005) 369-374
15. Greinacher A., Eichler P., Lubenow N., and Kiefel V. Drug-induced and drug-dependent immune thrombocytopenias. Rev Clin Exp Hematol 5 (2001) 166-200
16. Aster R.H. Drug-induced immune cytopenias. Toxicology 209 (2005) 149-153
17. Batchelor F.R., Dewdney J.M., and Gazzard D. Penicillin allergy: the formation of the penicilloyl determinant. Nature 206 (1965) 362-364
18. Weltzien H.U., and Padovan E. Molecular features of penicillin allergy. J Invest Dermatol 110 (1998) 203-206
19. Garratty G. Immune cytopenia associated with antibiotics. Transfus Med Rev 7 (1993) 255-267
20. dem Borne A.E., Pegels J.G., van der Stadt R.J., van der Plas-van Dalen C.M., and Helmerhorst F.M. Thrombocytopenia associated with gold therapy: a drug-induced autoimmune disease?. Br J Haematol 63 (1986) 509-516
21. Romagnoli P., Spinas G.A., and Sinigaglia F. Gold-specific T cells in rheumatoid arthritis patients treated with gold. J Clin Invest 89 (1992) 254-258
22. Curtis B.R., Divgi A., Garritty M., and Aster R.H. Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2 (2004) 985-992
23. McCorry R.B., and Johnston P. Fatal delayed thrombocytopenia following abciximab therapy. J Invasive Cardiol 18 (2006) 173-174
24. Bougie D.W., Wilker P.R., Wuitschick E.D., Curtis B.R., Malik M., Levine S., et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 100 (2002) 2071-2076
25. Brassard J.A., Curtis B.R., Cooper R.A., Ferguson J., Komocsar W., Ehardt M., et al. Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology. Thromb Haemost 88 (2002) 892-897
26. Arepally G.M., and Ortel T.L. Heparin-induced thrombocytopenia. N Engl J Med 355 (2006) 809-817
27. Aster R. Drug-induced thrombocytopenia. In: Michelson A.D. (Ed). Platelets (2007), Academic Press, New York 887-902
28. Warkentin T.E. Thrombocytopenia due to platelet destruction and hypersplenism. In: Hoffman R., Benz Jr. E.J., Shattil S.J., et al. (Eds). Hematology: basic principles and practice. 4th ed (2005), Elsevier, Philadelphia 2305-2325
29. Brinker A.D., and Beitz J. Spontaneous reports of thrombocytopenia in association with quinine: clinical attributes and timing related to regulatory action. Am J Hematol 70 (2002) 313-317
30. Reddy J.C., Shuman M.A., and Aster R.H. Quinine/quinidine-induced thrombocytopenia: a great imitator. Arch Intern Med 164 (2004) 218-220
31. Freiman J.P. Fatal quinine-induced thrombocytopenia. Ann Intern Med 112 (1990) 308-309
32. Brace L.D. Thrombocytopenia. Clin Lab Sci 20 (2007) 38-47
33. Marcelli-Barge A. Thrombopénies et leucopénies immunoallergiques d'origine médicamenteuse. Rev Fr Transf Hemobiol 32 (1989) 115-134
34. Portielje J.E., Westendorp R.G., Kluin-Nelemans H.C., and Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97 (2001) 2549-2554
35. Wazny L.D., and Ariano R.E. Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient. Pharmacotherapy 20 (2000) 292-307
36. Vicari A., Banfi G., and Bonini P.A. EDTA-dependent pseudothrombocytopaenia. A 12-month epidemiological study. Scand J Clin Lab Invest 48 (1988) 537-542
37. Visentin G.P., Wolfmeyer K., Newman P.J., and Aster R.H. Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 30 (1990) 694-700
38. Scognamiglio F., Corso C., Madeo D., Castaman G., Visco C., Borghero C., et al. Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases. Am J Hematol 83 (2008) 326-329
39. Bougie D., Johnson S.T., Weitekamp L.A., and Aster R.H. Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia. Blood 90 (1997) 407-413
40. Linkins L.A., and Warkentin T.E. The approach to heparin-induced thrombocytopenia. Semin Respir Crit Care Med 29 (2008) 66-74
41. Unkle D.W. Heparin-induced thrombocytopenia. Orthop Nurs 26 (2007) 383-387
42. Pourrat O. Treatment of drug-related diseases by plasma exchanges. Ann Med Interne 145 (1994) 357-360
43. Drews R.E. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med 24 (2003) 607-622
44. Pedersen-Bjergaard U., Andersen M., and Hansen P.B. Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol 52 (1997) 183-189